Timing matters more than dose too early post op can disrupt natural healing signaling

IGF 1 LR3 might accelerate repair but uncontrolled growth isn’t always beneficial

Most overlook inflammation phase  jumping in early could backfire

Anecdotes evidence clinical data here is still thin

Depends heavily on surgery type soft tissue vs orthopedic changes everything

Some report faster recovery others get excessive swelling mixed bag

Risk of fibrosis or abnormal tissue growth is underappreciated

Nutrition rehab likely gives 80% of results anyway

The endocrine environment post-surgery is already complex adding IGF isn’t trivial.

People ignore dosing frequency LR3’s long half life complicates control

Not all tissues respond equally to IGF-1 stimulation

Until solid trials exist this debate will stay opinion driven

Placebo expectation bias is strong in recovery discussions

Overuse mindset in forums leads to diminishing returns

Blood glucose management becomes relevant with IGF use

Could be more useful later in remodeling phase than acute phase